V

Vivaldi Biosciences Inc.

9 employees

Vivaldi Biosciences develops influenza vaccines and therapeutics for seasonal and pandemic influenza.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical Device
cell-based manufacture
virology
Universal influenza vaccine
Influenza vaccine
Covid-19 vaccine
Life Science

Date founded

2006

Funding rounds raised

Total raised

$23M

from 2 investors over 2 rounds

V

Vivaldi Biosciences Inc. raised $23M on January 21, 2009

Investors: Bay City Capital

V

Vivaldi Biosciences Inc. raised $2M on May 18, 2007

Investors: Bay City Capital

FAQ